Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pharma and biotech companies set their sites on sustainability

By Brian Buntz | December 17, 2021

Pharmaceutical Plant

Image courtesy of Wikimedia Commons

Sustainability continues to be a hot topic, and the pharmaceutical industry faces pressure to reduce its carbon footprint. As a result, a growing number of pharma companies are stepping up sustainability efforts.

In a growing number of locations, pharma companies are seeing drivers in the regulatory environment to force them to prioritize sustainability. “We’re seeing [pressure] from both regulatory authorities having jurisdiction at the federal, state and local level of different jurisdictions,” said Jeff Wegner, a mechanical engineer at CRB.

A growing number of jurisdictions on the East Coast and West Coast are restricting or banning the use of, for instance, natural gas.

While such restrictions are not yet pervasive, the trend is building, said Wegner, who was among the authors of the Horizons: Life Sciences Report.

Another dimension to sustainability is the fact that the pharmaceutical industry has been a big consumer of raw materials and energy. “It’s easy to kind of pick on pharma,” Wegner said. The industry is “responding positively, saying, ‘We can do better.'”

California is among the states moving quickest toward renewable energy; many other states have a long-term clean electricity goal or mandate.

A related trend is the pharma industry’s own quest to improve efficiency with strategies such as Pharma 4.0 while exploring emerging therapies such as advanced therapy medicinal products (ATMPs), which pose their own regulatory and logistics hurdles.

Big Pharma companies tend to be a bit more conservative in terms of digitalization, said Yvonne Duckworth, lead automation engineer and Pharma 4.0 subject matter expert at CRB.

“ATMPs tend to be a little bit more manual,” Duckworth said. “There’s a little less opportunity for automation.” Duckworth is a co-author of the report above.

But equipment vendors serving pharma and biotech are ensuring new equipment has connectivity, which can potentially help boost operational efficiency.

“Big Pharma tends to have more funding available for some of these additional digitalization projects as opposed to the less automated manufacturing of ATMPs,” Duckworth said.

In terms of Pharma 4.0 adoption overall, Duckworth acknowledges that the pharma industry has been more reserved in adopting such smart technologies than other industrial sectors such as the oil and gas industry.

But the tide may be turning given renewed support from regulatory authorities. The FDA, for instance, has implemented a new program called the Emerging Technology Program. “I think FDA realizes they have to change a little bit and help us to adopt this technology,” Duckworth said.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Moving toward the autonomous lab and what’s possible today
Female worker at pharmaceutical factory operating control panel of the pharmaceutical machine.
How real-time sensors and data-savvy can cut energy waste in pharma
Getinge DPTE-FLEX on a white background.
Getinge launches manual, externally openable port for pharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE